Minerva Advisors LLC Next Cure, Inc. Transaction History

Minerva Advisors LLC

  • $149 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jan 31, 2024
BUY
$1.46 - $1.83 $46,300 - $58,034
31,713 New
31,713 $46,000
Q4 2022

Jan 31, 2024
BUY
$1.2 - $3.07 $38,055 - $97,358
31,713 New
31,713 $44,000
Q4 2021

Feb 14, 2022
BUY
$5.7 - $9.1 $180,764 - $288,588
31,713 New
31,713 $190,000

Others Institutions Holding NXTC

# of Institutions
44
Shares Held
15.9M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $26.9M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Minerva Advisors LLC Portfolio

Follow Minerva Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Minerva Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Minerva Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email